This week we’ve seen financings and acquisitions news spanning the life sciences, IT, and cleantech sectors in New England.
—OpenMile, a Boston- and Chicago-based developer of Web and mobile technology for optimizing shipping, said it raised $6 million in a Series B deal led by Globespan Capital Partners, with participation from existing investor Charles River Ventures.
—Waltham, MA-based Bluespec, a maker of software for designing electronics components, grabbed $1 million in equity-based funding from four investors, an SEC filing showed. The company’s previous investors include Atlas Venture and North Bridge Venture Partners.
—DynamicOps, a Burlington, MA-based maker of software for cloud infrastructures and IT virtualization, snapped up an $11.3 million equity-based financing. The company was spun out of Credit Suisse in 2008.
—Marlborough, MA-based CardioFocus brought in $30.6 million to put toward its medical devices, which include a product for treating an irregular heart rhythm known as atrial fibrillation. The money comes from new investors First Alliance & Capital Invest, Fletcher Spaght Ventures, and Manatuck Hill Partners, as well as all of the startup’s previous investors.
—Boston non-profit Diagnostics For All nabbed a $3 million grant from the Bill & Melinda Gates Foundation and the UK’s Department for International Development to fund the creation of three new tests aimed at improving safety and productivity in agriculture. Diagnostics For All first spun out of Harvard to focus on diagnostic products in the human health space, and is led by veteran biotech executive Una Ryan.
—CHiL Semiconductor of Tewksbury, MA, said it is being acquired by Los Angeles-based power management firm International Rectifier (NYSE: [[ticker:IRF]]) in a $75 million cash deal expected to
